Table 2:
Analysis of variance (ANOVA) table for the effect of treatment [(Paclitaxel solution (PTX), 17-AAG solution (17-AAG), Paclitaxel+17-AAG solution each at half the concentration of individual drug solution and dual loaded nanoparticles (DLNP) containing the same drug concentration as PTX + 17-AAG)] and drug concentration on % viabilitySKBR3 cell line at 96 hours.
| Source | Sum of Squares | df | Mean Square | F-value | p-value | |
|---|---|---|---|---|---|---|
| Model | 1.20E+05 | 23 | 5200.54 | 377.73 | < 0.0001 | significant |
| A-Treatment | 29085.81 | 3 | 9695.27 | 704.19 | < 0.0001 | significant |
| B-Concentration | 61939.1 | 5 | 12387.8 | 899.76 | < 0.0001 | significant |
| Interaction (AB) | 28587.6 | 15 | 1905.84 | 138.43 | < 0.0001 | significant |
| Pure Error | 1321.72 | 96 | 13.77 | |||
| Cor Total | 1.21E+05 | 119 |